US Q2 Consumer Health Earnings Preview: Will More Favorable Year-Ago Comparisons Help?
Executive Summary
April-June sales of OTC drugs, supplements and personal care products likely will show at least notable and potentially strong increases from year-ago period when consumers slowed spending after splurging during 2020 Q1 as novel coronavirus pandemic sent shockwaves through the marketplace.
You may also be interested in...
It’s Official: Perrigo’s Entirely Consumer Health
"We are now a leading pure-play global consumer self-care company that has significant resources to invest,” says CEO Murray Kessler with Rx business sale closing.
P&G Introduces Nervive ‘Nerve Relief’ Supplements In US, Extending Line Acquired From Merck
P&G launches Nervive three-product line for nerve discomfort inspired by 50-year-old Neurobion brand marketed in Europe, Asia and Latin America. The products contain B-complex vitamins and alpha lipoic acid to promote blood flow.
J&J Consumer Health More Than A Revenue Stream: Driving Development Across Segments
CEO Alex Gorsky and medtech business leader Joaquin Duato say consumers’ growing interest in self-care is influencing the firm’s work across segments. Consumer health also is driver for Healthy Lives Mission to invest $800m through 2030 to improve the health of people and the world.